Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rocco

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patientsBarry I Freedman, Lilian Andries, Zak K Shihabi, et al.
Pilot and Feasibility Studies|June 20, 2020
A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility studyMariana Murea, Randolph L Geary, Denise K Houston, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 17, 2020
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: <i>Post Hoc</i> Analyses from SPRINTAlex R Chang, Holly Kramer, Guo Wei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 17, 2020
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus WorkshopEmma O'Lone, Andrea K Viecelli, Jonathan C Craig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2020
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial)Rakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patientsBarry I Freedman, Lilian Andries, Zak K Shihabi, et al.
Pilot and Feasibility Studies|June 20, 2020
A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility studyMariana Murea, Randolph L Geary, Denise K Houston, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 17, 2020
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: <i>Post Hoc</i> Analyses from SPRINTAlex R Chang, Holly Kramer, Guo Wei, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 17, 2020
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus WorkshopEmma O'Lone, Andrea K Viecelli, Jonathan C Craig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2020
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial)Rakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Pageof 22